Intraocular Pressure Variation from Brimonidine Use in Pterygium Surgery

Background: Pterygium is a common fibrovascular conjunctival lesion in tropical countries such as Bangladesh, and bleeding from its vascular bed can obscure the surgical field. Brimonidine tartrate, a selective α2-adrenergic agonist used to lower intraocular pressure (IOP), also causes conjunctival vasoconstriction and is applied during surgery for hemostasis, but its effect on IOP after pterygium excision is unclear. Objective: To evaluate the change in IOP following peroperative use of brimonidine in pterygium surgery. Methodology: This comparative observational study was conducted in the Cornea Department of Ispahani Islamia Eye Institute and Hospital, Dhaka, on 70 eyes of 70 consecutive patients undergoing pterygium excision. Brimonidine 0.2%-soaked applicators were used for hemostasis in 45 eyes; 25 eyes received conventional hemostasis. IOP was measured by non-contact tonometry preoperatively and on the first or second postoperative day and analyzed with IBM SPSS Statistics version 27 using paired and Welch t tests. Results: The mean age was 48.3±13.3 years and 42 (60.0%) patients were male. Overall IOP changed from 13.1±2.9 to 12.8±2.9 mmHg (mean change −0.27 mmHg, 95% CI −0.93 to 0.39; p=0.41). The mean change was +0.04 mmHg with brimonidine (p=0.92) and −0.84 mmHg without it (p=0.11); the between-group difference was not significant (p=0.19). Postoperative IOP ≥21 mmHg and a rise ≥6 mmHg each occurred in 3 (4.3%) eyes. Conclusion: Peroperative brimonidine used for hemostasis in pterygium surgery neither significantly lowered nor raised early postoperative IOP and appears safe in non-glaucomatous eyes. J. Natl.Inst.Ophthalmol.2025;8(2): 34-39

Authors

Institutions

Publication Details

Journal
Journal of National Institute of Ophthalmology
Published
2026-11-19
DOI
https://doi.org/10.3329/jnio.v8i2.95130
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Intraocular Pressure Variation from Brimonidine Use in Pterygium Surgery

Yusuf Jamal Khan, Ashfia Farhin Huq, Md Rajeeb Alam, Sidratul Muntaha Naznin et al.
Journal of National Institute of Ophthalmology
Glaucoma and retinal disorders
article

Intraocular Pressure Variation from Brimonidine Use in Pterygium Surgery

Yusuf Jamal Khan, Ashfia Farhin Huq, Md Rajeeb Alam, Sidratul Muntaha Naznin, Md Lutfuzzahan, A S M Moin Uddin
article en

Abstract

Background: Pterygium is a common fibrovascular conjunctival lesion in tropical countries such as Bangladesh, and bleeding from its vascular bed can obscure the surgical field. Brimonidine tartrate, a selective α2-adrenergic agonist used to lower intraocular pressure (IOP), also causes conjunctival vasoconstriction and is applied during surgery for hemostasis, but its effect on IOP after pterygium excision is unclear. Objective: To evaluate the change in IOP following peroperative use of brimonidine in pterygium surgery. Methodology: This comparative observational study was conducted in the Cornea Department of Ispahani Islamia Eye Institute and Hospital, Dhaka, on 70 eyes of 70 consecutive patients undergoing pterygium excision. Brimonidine 0.2%-soaked applicators were used for hemostasis in 45 eyes; 25 eyes received conventional hemostasis. IOP was measured by non-contact tonometry preoperatively and on the first or second postoperative day and analyzed with IBM SPSS Statistics version 27 using paired and Welch t tests. Results: The mean age was 48.3±13.3 years and 42 (60.0%) patients were male. Overall IOP changed from 13.1±2.9 to 12.8±2.9 mmHg (mean change −0.27 mmHg, 95% CI −0.93 to 0.39; p=0.41). The mean change was +0.04 mmHg with brimonidine (p=0.92) and −0.84 mmHg without it (p=0.11); the between-group difference was not significant (p=0.19). Postoperative IOP ≥21 mmHg and a rise ≥6 mmHg each occurred in 3 (4.3%) eyes. Conclusion: Peroperative brimonidine used for hemostasis in pterygium surgery neither significantly lowered nor raised early postoperative IOP and appears safe in non-glaucomatous eyes. J. Natl.Inst.Ophthalmol.2025;8(2): 34-39

Journal of National Institute of OphthalmologyVol. 8(2)
Ispahani Islamia Eye Institute and Hospital (BD)
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon